ACAD - ACADIA Pharmaceuticals Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1331414
Avg. Estimate-0.36-0.39-1.62-1.3
Low Estimate-0.42-0.43-1.68-2.11
High Estimate-0.32-0.37-1.580.45
Year Ago EPS-0.5-0.59-1.94-1.62
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts1341414
Avg. Estimate96.57M97.2M337.37M462.37M
Low Estimate94.36M91.8M335.11M372.31M
High Estimate100M102M340.75M693.18M
Year Ago Sales59.57M60.69M223.81M337.37M
Sales Growth (year/est)62.10%60.20%50.70%37.10%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.55-0.52-0.45-0.4
EPS Actual-0.5-0.59-0.38-0.29
Difference0.05-0.070.070.11
Surprise %9.10%-13.50%15.60%27.50%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.36-0.39-1.62-1.3
7 Days Ago-0.36-0.42-1.62-1.3
30 Days Ago-0.36-0.42-1.62-1.3
60 Days Ago-0.4-0.48-1.78-1.36
90 Days Ago-0.41-0.49-1.84-1.37
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesACADIndustrySectorS&P 500
Current Qtr.28.00%N/AN/A0.01
Next Qtr.33.90%N/AN/A0.06
Current Year16.50%N/AN/A-0.03
Next Year19.80%N/AN/A0.14
Next 5 Years (per annum)26.50%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A